Different lipid signature in fibroblasts of long-chain fatty acid oxidation disorders

17Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

Long-chain fatty acid oxidation disorders (lc-FAOD) are a group of diseases affecting the degradation of long-chain fatty acids. In order to investigate the disease specific alterations of the cellular lipidome, we performed undirected lipidomics in fibroblasts from patients with carnitine palmitoyltransferase II, very long-chain acyl-CoA dehydrogenase, and long-chain 3-hydroxyacylCoA dehydrogenase. We demonstrate a deep remodeling of mitochondrial cardiolipins. The aberrant phosphatidylcholine/phosphatidylethanolamine ratio and the increased content of plasmalogens and of lysophospholipids support the theory of an inflammatory phenotype in lc-FAOD. Moreover, we describe increased ratios of sphingomyelin/ceramide and sphingomyelin/hexosylceramide in LCHAD deficiency which may contribute to the neuropathic phenotype of LCHADD/mitochondrial trifunctional protein deficiency.

Cite

CITATION STYLE

APA

Alatibi, K. I., Hagenbuchner, J., Wehbe, Z., Karall, D., Ausserlechner, M. J., Vockley, J., … Tucci, S. (2021). Different lipid signature in fibroblasts of long-chain fatty acid oxidation disorders. Cells, 10(5). https://doi.org/10.3390/cells10051239

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free